Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2409021 blood pressure study in adults with type 2 diabetes mellitus
2013-003834-33Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of adomeglivant in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change from baseline in mean ABPM 24-hour systolic blood pressure. Started Dec 2013; status: completed.
02
Drugs
adomeglivant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-003834-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003834-33.